引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 396次   下载 230 本文二维码信息
码上扫一扫!
车叶草苷调节SIRT1/AMPK信号通路对结直肠癌细胞恶性进展的影响
许明月,付文政
天津市人民医院南开大学第一附属医院肛肠病诊疗中心,天津市大肠肛门病研究所天津 300121
摘要:
目的:探讨车叶草苷调节沉默信息调节因子2相关酶1(SIRT1)/腺苷酸活化蛋白激酶(AMPK)信号通路对结直肠癌细胞恶性进展的影响。方法:体外培养人结直肠癌细胞HCT116并构建其裸鼠移植瘤模型,通过检测不同浓度车叶草苷处理下HCT116细胞活力与不同剂量车叶草苷处理下裸鼠肿瘤生长情况,筛选出车叶草苷的最佳体外细胞作用浓度和体内裸鼠作用剂量。将HCT116细胞及其裸鼠模型随机均分为对照组、车叶草苷组、Ex-527(SIRT1抑制剂)组、车叶草苷+Ex-527组,分组处理后,以CCK-8法、流式细胞术、Transwell实验、细胞划痕实验分别检测各组HCT116细胞活力、凋亡、迁移与侵袭;检测裸鼠肿瘤体积并以免疫组化染色检测各组裸鼠肿瘤细胞生长(Ki67阳性率)与微血管密度(CD34阳性率);以免疫印迹法检测各组HCT116细胞与裸鼠肿瘤增殖(PCNA)、凋亡(Bax、Cleaved caspase-3、caspase-3)、上皮间质转化(EMT)(E-cadherin、Vimentin)、SIRT1/AMPK信号通路相关蛋白表达。结果:对照组相比,车叶草苷组HCT116细胞凋亡率、Bax及Cleaved caspase-3、caspase-3、E-cadherin、SIRT1蛋白表达、p-AMPK/AMPK升高(P <0.05),细胞活力、侵袭数、迁移率、肿瘤体积、Ki67与CD34阳性率、PCNA与Vimentin蛋白表达降低(P <0.05);Ex-527组HCT116细胞各指标变化趋势与车叶草苷组相反。Ex-527可消除车叶草苷对HCT116细胞恶性进展的抑制作用。结论:车叶草苷通过激活SIRT1/AMPK信号通路而抑制结直肠癌细胞体外迁移、侵袭与增殖,并促进其凋亡,抑制其在裸鼠体内生长,最终延缓结直肠癌恶性进展。
关键词:  车叶草苷  沉默信息调节因子2相关酶1/腺苷酸活化蛋白激酶  结直肠癌  恶性进展
DOI:10.3969/j.issn.1007-6948.2025.06.021
投稿时间:2024-12-03
基金项目:国家中医药管理局中西医协同“旗舰”科室建设项目、天津市中西医结合重点专科建设项目、天津市科技局重点项目(23JCZDJC01250)
Effect of Asperuloside on the malignant progression of colorectal cancer cells by regulating the SIRT1/AMPK signaling pathway
XU Ming-yue,FU Wen-zheng
Department of Colorectal Surgery, Tianjin Union Medical Center; Tianjin Coloproctology Institute, Tianjin300071, China
Abstract:
Objective To investigate the effect of Asperuloside on the malignant progression of colorectal cancer cells by regulating the silent mating type information regulation 2 homolog-1 (SIRT1)/adenosine monophosphate activated protein kinase (AMPK) signaling pathway. Methods Human colorectal cancer cell line HCT116 was cultured in vitro and its nude mouse transplantation model was constructed. The viability of HCT116 cells under different concentrations of Asperuloside treatment and the tumor growth in nude mice under different doses of Asperuloside treatment were detected to screen for the optimal in vitro cell action concentration and in vivo nude mouse action dose of Asperuloside. HCT116 cells and their nude mouse models were randomly separated into a control group, a Asperuloside group, an Ex-527 (SIRT1 inhibitor) group, and a Asperuloside+Ex-527 group. After grouping, CCK-8 assay, flow cytometry, Transwell assay, and cell scratch assay were applied to detect the cell viability, apoptosis, migration, and invasion of HCT116 cells in each group. The tumor volume of nude mice was detected, and immunohistochemical staining was applied to detect the growth of tumor cells (Ki67 positive rate) and microvascular density (CD34 positive rate) of nude mice in each group. Immunoblotting was applied to detect the expression of proteins related to the proliferation (PCNA), apoptosis (Bax, Cleaved caspase-3, caspase-3), epithelial mesenchymal transition (EMT) (E-cadherin, Vimentin), and SIRT1/AMPK signaling pathway in HCT116 cells and nude mice in each group. Results Compared with the control group, the apoptosis rate of HCT116 cells, Bax and Cleaved caspase-3, caspase-3, E-cadherin, SIRT1 protein expression, and p-AMPK/AMPK were increased in the Asperuloside group (P <0.05), the cell viability, invasion number, migration rate, tumor volume, Ki67 and CD34 positive rates, PCNA and Vimentin protein expression were reduced (P <0.05); the trend of changes in various indicators of HCT116 cells in the Ex-527 group was opposite to that in the Asperuloside group. Ex-527 can eliminate the inhibitory effect of coumarin on the malignant progression of HCT116 cells. Conclusion Asperuloside inhibits the in vitro migration, invasion, and proliferation of colorectal cancer cells by activating the SIRT1/AMPK signaling pathway, promotes apoptosis, inhibits their growth in nude mice, and ultimately delays the malignant progression of colorectal cancer.
Key words:  Asperuloside  SIRT1/AMPK  colorectal cancer  malignant progression

用微信扫一扫

用微信扫一扫